Serial Number
79256886
Owner
IFOM Fondazione Istituto FIRC di Oncologia MolecolareAttorney
KENNETH F FLOREKFiling Date
Sep 20, 2018
IFOM Trademark
Serial Number: 79256886 • Registration: 6297449
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Via Adamello, 16
Entity Type: 99
Legal Representation
Correspondence Address
KENNETH F FLOREK FLOREK & ENDRES PLLC
552 SEVENTH AVENUE, SUITE 601
NEW YORK, NY 10018
UNITED STATES
Trademark Details
Filing Date
September 20, 2018
Registration Date
March 23, 2021
Published for Opposition
June 2, 2020
Goods & Services
Pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the prevention of disorders of the skeletal system; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of disorders of the central nervous system related to cancer, aging and metabolic diseases; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of disorders of the circulatory system related to aging; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of hormonal disorders and diabetes; pharmaceutical cough preparations; preparations for treating colds; pharmaceutical preparations for the treatment of flu and headache; pharmaceutical preparations for the treatment of stomach disorders; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for treating muscular and/or rheumatological diseases; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating allergies; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for use in oncology; diagnostic preparations and reagents for medical use in a clinic or medical laboratory; hormones; dietetic substances adapted for medical use, in particular, nutritional supplements, vitamin preparations, herbal supplements and preparations, nutritional drink mixes for use as meal replacements for medical use, meal replacement snacks for medical purposes; food and drinks for babies, infant formula and dietetic products for invalids, in particular food for babies, powdered milk for babies, foods for enteral feedings and dietetic foods adapted for medical purposes
Medical services, health care services in the field of oncology, aging and metabolic diseases, medical assistance, physical rehabilitation in the field of oncology; hospital services; consulting services in the field of medical care, namely, consultancy in the field of medical diagnosis, medical analysis and RNA or DNA analysis for cancer diagnosis and prognosis; consulting services relating to health care
Scientific and technological services, namely, scientific research, analysis, testing, diagnosis and screening in the field of oncology and cancer research; research and development in the field of oncology, aging and metabolic diseases; scientific and industrial research and analysis services, namely, scientific research, analysis, testing in the field of medicine; biological research and analysis; scientific, clinical and medical research in the field of radiology, chemotherapy, pharmacotherapy, coronary artery bypass surgery; basic and clinical research in the field of genetics, stem cell, immunodeficiency and neurodegenerative diseases, proteomics, bioinformatics, neurobiology and molecular biology and diabetes; scientific research in the field of medicine; consultancy in the field of scientific analysis; none of the foregoing to include educational testing